688639 華恒生物
按盤價 
41.340 +5.010 (+13.790%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.389 | 8.631 | 27.154 | 24.030 | 20.113 |
| 總資產報酬率 ROA (%) | 3.145 | 4.231 | 14.975 | 18.281 | 15.177 |
| 投入資產回報率 ROIC (%) | 3.657 | 5.131 | 18.744 | 22.267 | 18.626 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.550 | 24.924 | 40.516 | 38.659 | 32.330 |
| 營業利潤率 (%) | 7.953 | 9.152 | 26.359 | 24.111 | 19.531 |
| 息稅前利潤/營業總收入 (%) | 9.107 | 10.285 | 26.280 | 23.703 | 19.975 |
| 淨利潤/營業總收入 (%) | 7.268 | 8.474 | 23.041 | 22.510 | 17.633 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.020 | 79.903 | 96.897 | 95.154 | 88.745 |
| 價值變動淨收益/利潤總額(%) | -0.944 | 0.424 | 0.503 | 2.183 | 3.431 |
| 營業外收支淨額/利潤總額(%) | -1.823 | 1.037 | -0.915 | 0.274 | 2.329 | 償債能力分析 |
| 流動比率 (X) | 1.445 | 0.843 | 0.626 | 2.220 | 4.661 |
| 速動比率 (X) | 1.005 | 0.589 | 0.491 | 1.871 | 4.080 |
| 資產負債率 (%) | 52.964 | 48.724 | 54.016 | 26.908 | 19.740 |
| 帶息債務/全部投入資本 (%) | 41.413 | 34.880 | 36.982 | -0.233 | -4.042 |
| 股東權益/帶息債務 (%) | 131.178 | 173.836 | 156.433 | -38,972.633 | -2,358.525 |
| 股東權益/負債合計 (%) | 89.288 | 105.497 | 85.190 | 271.431 | 406.598 |
| 利息保障倍數 (X) | 7.024 | 9.913 | 164.477 | -50.050 | -919.204 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 33.954 | 43.767 | 47.003 | 55.343 | 49.860 |
| 存貨周轉天數 (天) | 73.299 | 69.726 | 56.512 | 50.000 | 42.743 |
| 備註： | 即時報價更新時間為 13/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
